SCHEMBL6233755

SCHEMBL6233755

CC(C)c1ccc(NN2C(=O)c3[nH]c4cc(Cl)ccc4c(=O)c3C2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 4/20 0.40
CLK4 Q9HAZ1 4/20 0.40
AXL P30530 1/20 0.40
PTK2B Q14289 1/20 0.40
MAPKAPK5 Q8IW41 1/20 0.40
SRPK1 Q96SB4 1/20 0.40
FLT3 P36888 2/20 0.39
ERBB2 P04626 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CSNK1G1 Q9HCP0 1/20 0.38
HAVCR2 Q8TDQ0 1/20 0.38
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
AURKA O14965 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6231910 0.91 PIM1 (0.44) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6232252 0.89 LMNA (0.42) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6231904 0.89 CA1 (0.41) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6231125 0.87 PIM1 (0.47) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6239738 0.86 CA1 (0.50) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6233199 0.86 CYP19A1 (0.42) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6233754 0.80 MAPK13 (0.40) CA1CA2GSK3BLMNACA9
SCHEMBL6231824 0.76 TUBB4A (0.42) PIM1CLK4CA1CA2IGF1R
SCHEMBL6236235 0.76 KDM4E (0.39) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6232338 0.76 CA1 (0.44) PIM1CLK4AXLPTK2BMAPKAPK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1004582-B1 Pyridazino quinoline compounds ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
EP-0790996-B1 PYRIDAZINOQUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2002-03-27 EP disclosed
US-6232313-B1 TREATING STROKE OR EPILEPTIC CONVULSIONS ASSOCIATED WITH EXCESSIVE CALCIUM INFLUX IN THE BRAIN CAUSED BY EXCITATORY AMINO ACIDS ZENECA LIMITED (GB) 2001-05-15 US disclosed
US-6214826-B1 NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 2001-04-10 US disclosed
EP-0724583-B1 PYRIDAZINO QUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2000-12-13 EP disclosed
EP-1004582-A2 Pyridazino quinoline compounds AstraZeneca UK Limited (GB) 2000-05-31 EP disclosed
US-5744471-A NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 1998-04-28 US disclosed
EP-0790996-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1997-08-27 EP disclosed
EP-0724583-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-08-07 EP disclosed
WO-1996015127-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-05-23 WO disclosed
WO-1995011244-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1995-04-27 WO disclosed